GLENMEDE TRUST CO NA - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 233 filers reported holding BEAM THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.23 and the average weighting 0.4%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$216,000
-49.2%
4,552
-38.8%
0.00%
-50.0%
Q1 2022$425,000
-27.7%
7,437
+0.7%
0.00%
-33.3%
Q4 2021$588,000
-7.1%
7,387
+1.4%
0.00%0.0%
Q3 2021$633,000
-33.0%
7,287
-0.8%
0.00%
-40.0%
Q2 2021$945,000
+166.2%
7,343
+65.4%
0.01%
+150.0%
Q1 2021$355,000
+45.5%
4,440
+48.0%
0.00%
+100.0%
Q4 2020$244,000
+234.2%
3,0000.0%0.00%
Q3 2020$73,0003,0000.00%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$205,573,00024.93%
HSG Holding Ltd 796,089$69,268,0006.22%
DC Investments Management, LLC 21,010$1,828,0003.41%
Redmile Group, LLC 1,975,006$171,845,0003.00%
Casdin Capital, LLC 818,820$71,246,0001.77%
Evolutionary Tree Capital Management, LLC 44,390$3,862,0001.71%
HHLR ADVISORS, LTD. 1,448,161$126,004,0001.65%
Nan Fung Group Holdings Ltd 54,903$4,777,0001.53%
ARK Investment Management 6,841,722$595,298,0001.43%
BRANDYWINE MANAGERS, LLC 12,900$1,122,0001.17%
View complete list of BEAM THERAPEUTICS INC shareholders